Clinical Trials: Cancer/Tumors

California

Duarte; City of Hope
PHI-59 NCI #8057: Phase I and Pharmacokinetic Study of Vorinostat for Solid Tumors and Lymphomas in Patients with Varying Degrees of Hepatic Dysfunction

Duarte; City of Hope
Molecular Genetic Studies in Cancer Patients and Their Relatives

Duarte; City of Hope
A Phase I Study of Yttrium-90 Labeled Humanized Anti-CEA M5A Antibody in Patients with CEA Producing Advanced Malignancies

Duarte; City of Hope
PHI-16: Phase I Trial of 5-Fluoro-2'-deoxycytidine with Tetrahydrouridine

Duarte; City of Hope
A Phase I, Open-Label, Dose Escalation First Time in Human Study to Evaluate the Safety Profile, Pharmacokinetics and Pharmacodynamics of GSK923295 in Subjects with Refractory Cancers

Duarte; City of Hope
RTOG 0529: A Phase II Evaluation of Dose-Painted IMRT in Combination with 5-Fluorouracil and Mitomycin-C for Reduction of Acute Morbidity in Carcinoma of the Anal Canal

New York

New York; Biomedical Research Alliance of New York
Clinical trial to test a study drug in the prevention of mouth inflammation in cancer patients receiving stem cell transplant

New York; Biomedical Research Alliance of New York
Small Cell Lung Cancer (SCLC) - Relapsed or Failed Chemotherapy

Ohio

Cincinnati; Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
Rare Benign Vascular Tumor Registry